TrialAnnals of hematology2007

CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.

Marry M van den Heuvel-Eibrink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.